Featured Research

from universities, journals, and other organizations

Statin therapy before coronary artery bypass grafting may improve outcomes

Date:
October 1, 2013
Source:
Society of Thoracic Surgeons
Summary:
Patients receiving statin therapy before coronary artery bypass grafting (CABG) surgery appear to have a reduced risk of post-surgical mortality, stroke, and atrial fibrillation (irregular or rapid heart rate).

Patients receiving statin therapy before coronary artery bypass grafting (CABG) surgery appear to have a reduced risk of post-surgical mortality, stroke, and atrial fibrillation (irregular or rapid heart rate), according to an article in the October 2013 issue of The Annals of Thoracic Surgery. These same benefits from statins could not be demonstrated for patients undergoing aortic valve replacement (AVR).

Related Articles


"Heart surgery patients typically have a number of other disorders, so we need to optimize the patient's preoperative condition and help ensure the best possible result," said Elmar W. Kuhn, MD, from the University of Cologne in Germany.

Statins are commonly used to lower levels of low-density lipoprotein (LDL), also known as "bad" cholesterol, which helps reduce the risk of cardiovascular disease in those at high risk.

Previous research has shown that statin therapy is beneficial for bypass patients in some trials, but other studies failed to confirm this effect. Dr. Kuhn, Oliver J. Liakopoulos, MD, and colleagues analyzed current research to see if preoperative statin therapy improved results for isolated CABG and AVR operations.

The analysis included 36 studies, 32 of which assessed statin treatment before CABG surgery with a total of 36,053 patients, and four that analyzed statin effects in a total of 3,091 patients undergoing AVR surgery.

Overall, the mortality rate among patients taking statins before CABG surgery was lower than the mortality rate among patients not taking statins, and a 19% reduction in the risk of stroke was found among patients taking statins compared to the control group. No significant reduction was found in the risk of heart attack or atrial fibrillation.

For AVR, statin therapy before surgery produced no significant differences in any of these post-surgical outcomes.

"Our result underlines the importance of statin therapy before CABG procedures," said Dr. Liakopoulos. "We therefore hope that more patients are treated with statins prior to bypass surgery, but recognize that our work may not impact the current care for patients undergoing aortic valve replacement. In general, we believe these results can prompt greater efforts to improve preoperative management."

The American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines recommends statin treatment for all patients undergoing CABG surgery, regardless of their LDL levels before surgery.


Story Source:

The above story is based on materials provided by Society of Thoracic Surgeons. Note: Materials may be edited for content and length.


Journal Reference:

  1. Elmar W. Kuhn, Oliver J. Liakopoulos, Sebastian Stange, Antje-Christin Deppe, Ingo Slottosch, Maximilian Scherner, Yeong-Hoon Choi, Thorsten Wahlers. Meta-Analysis of Patients Taking Statins Before Revascularization and Aortic Valve Surgery. The Annals of Thoracic Surgery, 2013; 96 (4): 1508 DOI: 10.1016/j.athoracsur.2013.04.096

Cite This Page:

Society of Thoracic Surgeons. "Statin therapy before coronary artery bypass grafting may improve outcomes." ScienceDaily. ScienceDaily, 1 October 2013. <www.sciencedaily.com/releases/2013/10/131001090006.htm>.
Society of Thoracic Surgeons. (2013, October 1). Statin therapy before coronary artery bypass grafting may improve outcomes. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2013/10/131001090006.htm
Society of Thoracic Surgeons. "Statin therapy before coronary artery bypass grafting may improve outcomes." ScienceDaily. www.sciencedaily.com/releases/2013/10/131001090006.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins